Kate Johnson MSc, PhD
Assistant Professor (Grant Tenure Track)
Division of Respiratory Medicine, Department of Medicine, Faculty of Medicine
Kate Johnson is an assistant professor with a joint appointment in the Faculty of Pharmaceutical Sciences and Division of Respiratory Medicine, Department of Medicine. She completed her PhD in the Faculty of Pharmaceutical Sciences followed by a postdoctoral fellowship in health economics at the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington.
Dr. Johnson is a health economics and outcomes researcher specializing in simulation modeling and comparative effectiveness evaluation with applications to respiratory disease. The overarching themes of her research are real-world evidence generation to understand disease trajectory and patterns of care, followed by simulation modeling to evaluate healthcare interventions for reducing the burden of disease on patients and the healthcare system. This work incorporates methods from epidemiology, health economics, and data science, applied to practical questions for improving the delivery of healthcare and effectiveness of interventions in respiratory medicine. Her work addresses health policy questions in the areas of 1) medication access, 2) whole disease modeling of asthma and COPD with an emphasis on evaluating strategies for prevention and early intervention, 3) the impacts of air pollution on the burden of respiratory disease and the value of climate mitigation strategies, and 4) healthcare sustainability.
Johnson KM, Cheng L, Yin Y, Carter R, Chow S, Brigham E, Law MR. The Impact of Eliminating Out-of-Pocket Payments on Asthma Medication Use. Annals of the American Thoracic Society. 2024 Aug 6. PMID: 39106523.
Adibi A, Barn P, Shellington E, Harvard S, Johnson KM*, Carlsten C*. HEPA Air Filters for Preventing Wildfire-Related Asthma Complications, a Cost-effectiveness Study. American Journal of Respiratory and Critical Care Medicine. 2024 Jan 15;209(2):175–184. PMID: 37917367 (*co-senior authors).
Amegadzie JE, Lee TY, Sadatsafavi M, Lynd LL, Sin D, Johnson KM. Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease over 16 Years in Canada. CMAJ. 2023 Sept 11;195(35): E1172–E1179. PMID: 37696554.
Mountain R, Duan K, Johnson KM. Benefit-harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbations in Patients with COPD. Annals of the American Thoracic Society. 2024 Aug;21(8):1139–1146.PMID: 38578813.
Johnson KM, Sadatsafavi M, Adibi A, Lynd LD, Harrison M, Tavakoli H, Sin DD, Bryan S. Cost-Effectiveness of Case Detection Strategies for the Early Detection of COPD. Applied Health Economics and Health Policy. 2021;19: 203–215.
Contact Details
Office 4624, Pharmaceutical Sciences Building